GLOBAL SYRINGE AND NEEDLE MARKET SIZE TO CROSS USD 34 BILLION BY 2025, GROWING AT A CAGR OF 10% DURING THE FORECAST PERIOD

Syringe and Needle Market Size, Share, & Trends Analysis Report By Products (Syringes and Needles), Patient Group (Adults and Pediatric Patients), End-users (Hospitals, Clinics, Home Healthcare Settings, and Others), and Geography (North America, Europe, APAC, Latin America, and Middle East & Africa), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020-2025

GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Customize this Report

Most Exhaustive Report

292 Pages

70 Tables

155 Charts

5 Regions

19 Countries

41 Companies

4 Market Segment

Syringe and Needle MarkeT REPORT SCOPE

Report Attribute Details
MARKET SIZE (Revenue) USD 34 Billion (2025)
CAGR 10% (2020-2025)
BASE YEAR 2019
FORECAST PERIOD 2020-2025
MARKET SEGMENTATION Products (Syringes and Needles), Patient Group (Adults and Pediatric Patients ), and End-users (Hospitals, Clinics, Home Healthcare Settings, and Others)
GEOGRAPHICAL ANALYSIS North America, Europe, APAC, Latin America, and Middle East & Africa
COUNTRIES COVERED US, Canada, UK, Germany, Russia, France, Italy, Spain, Japan, China, India, South Korea, Australia Brazil, Mexico, Argentine, South Africa, Saudi Arabia, and Turkey

INDUSTRY INSIGHTS 

The global syringe and needle market size to cross USD 34 billion by 2025, growing at a CAGR of 10% during the forecast period. The global syringe and needle market constitutes an essential segment of the global medical devices market. The market is majorly driven by the rising incidence of trauma cases (accidents and burn cases), the growing prevalence of chronic diseases, and the increasing incidence of hospital-acquired infections. Chronic diseases such as diabetes require medical products such as needles and syringes for the administration of insulin and drawing blood samples for monitoring glucose levels. Hence, the market is likely to grow due to the increasing prevalence of diabetics across the globe. With increasing instances of hospital-acquired infections, there is a high demand to reduce hospital-acquired infections and maintain safe laboratory practices. Hence, the increased focus to avoid needle stick injuries and infection transmissions by medical practitioners is boosting the growth of safety syringes and needles in the market. 

SNIPPETS

  • The adult segment is expected to grow at a faster growth rate than the pediatric segment and is expected to account for 91% absolute growth during the forecast period.
  • The demand for self-administered injectable devices and prefilled syringes for drug delivery is growing at a significant rate to prevent infection risks and avoid needle stick injuries.
  • North America is likely to dominate the needle and syringe market during the forecast period; however, the APAC region is projected to grow at the fastest CAGR during the forecast period.
  • The syringe and needle market in India is expected to observe an incremental growth of over $113 billion.

GLOBAL SYRINGE AND NEEDLE MARKET SEGMENTATION

This research report includes a detailed segmentation by

  • Products
  • Patient Group
  • End-users
  • Geography

INSIGHTS BY PRODUCTS

North America dominates the syringe market. APAC is expected to grow at a faster growth rate due to the presence of a large patient population that requires syringes for medication and blood testing. The increased adoption of injectable drugs, technological advancements, the increase in the geriatric population, and the growing number of vaccination and immunization programs for pediatrics, as well as adults, are expected to drive the volume growth over the next few years. The syringe market is categorized based on type and usability. By type, the segment is further divided into general and specialized syringes. The general segment dominated the market in 2019, while the specialized segment is expected to grow at a faster growth rate during the forecast period. In terms of usability, the syringes segment is segmented into disposable and sterilizable. The disposable segment dominated the market share of 90%. The sterilizable segment accounted for a 10% market share.

The needles segment is growing, with an incremental growth of $4.78 billion. This growth is due to the increasing demand for needles to administrate drugs and supply nutrients to patients. The increasing prevalence of diabetes is boosting the demand for injecting insulin. Also, the increasing patient population due to the pandemic cases of COVID-19 is increasing the demand for needles and syringes during the forecast period.  

INSIGHTS BY PATIENT GROUP

The adult segment accounted for a 65% share of the global market in 2019. The segment is the major revenue contributor on account of the increasing application of injections to treat diseases such as cancer, diabetes, and several viral infections. The growing elderly population, which is prone to chronic diseases, is another major revenue contributor to the healthcare industry as this patient group requires medical supervision. The rise in hospital admissions is due to the increase in cancer, cardiovascular ailments, and other infectious and chronic diseases prevalence has driven the demand for syringes and needles.

The pediatric segment is expected to grow at the fastest CAGR during the forecast period. The segment is driven by improving birth rates across the world, boosting the usage of injections. Moreover, the increase in chronic disease prevalence in the pediatric population is one of the significant factors that is driving the usage of syringes and needles. It has been estimated that chronic health conditions affect 10% to 30% of children across the world.

INSIGHTS BY END-USERS

The hospital end-user segment is dominating the market and accounted for a 55% market share of the global syringe and needle market in 2019. Hospitals are the major revenue contributors. All hospitals use needles and syringes to withdraw blood or fluid samples and administer drugs or vaccinations. In emergency and inpatient settings, the injections are used on a large scale for medication and collection of multiple blood specimens for diagnosis and treatment purposes for the patients in critical care.

The syringe and needle market is witnessing the growing adoption of advanced syringes to minimize the risk of vessel intima. Advanced and safety needles and syringes are reducing the risk of needle stick injuries and transmission of infectious diseases among patients and healthcare providers. The outbreak of the COVID-19 pandemic is increasing hospital admissions, thereby increasing the demand for injections.

The clinic end-user segment is expected to grow at a CAGR of over 9% during the period 2019¬2025. IVF and rehabilitation clinics use a high number of needles and syringes for medical and vaccination procedures, thereby boosting the market. Similarly, the home care setting segment is expected to experience growth as the elderly population prefers these settings over hospitals and other clinics.

INSIGHTS BY GEOGRAPHY

The North American region is driven by the rising incidence of chronic and infectious diseases, with hospitals, clinics, and ASCs emerging as the major revenue generators. The US and Canada are the primary revenue contributors to the market. The adoption of syringes and needles with safety mechanisms is higher in North America than in other geographical regions. End-users prefer the use of safety-engineered products, which, in turn, has increased the demand for such products. Moreover, the practice of safe community disposal has helped reduce medical contamination from needles, syringes, and cannula. The market is growing at a significant pace, which is expected to continue during the forecast period due to the rise in demand for safety injections and advanced cannula to reduce the incidences of needle stick injuries. 

INSIGHTS BY VENDORS

The global syringes and needle market share is fragmented and is currently intensifying due to the rapidly changing technological environment. Becton, Dickinson and Company, B Braun Melsungen, Nipro Corporation, Terumo, and Teleflex are the key players. All these companies have a significant presence in major geographical regions such as North America, APAC, and Europe. However, there are many local vendors providing products with similar specifications at low prices, which results in the price war among vendors. The major vendors are competing among themselves for the leading position in the market, with occasional spurts of competition coming from other local vendors.

The global syringe and needle market research report includes in-depth coverage of the industry analysis with revenue and forecast insights for the following segments:

Segmentation by Products  

  • Syringes
    • Types
      • General Syringes
      • Specialized Syringes
    • Usability
      • Disposable Syringes
      • Sterilizable Syringes
  • Needles
    • Types
      • Conventional Needles
      • Safety Needles 

By Patient Group

  • Adults
  • Pediatric Patients 

By End-users  

  • Hospitals
  • Clinics
  • Home Healthcare Settings
  • Others 

By Geography

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Russia
  • APAC
    • China
    • Japan
    • South Korea
    • Australia
    • India
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Turkey

Frequently Asked Questions

Syringe and needle market size is expected reach revenues of over $34 billion by 2025, growing at a CAGR of 10% during the forecast period
The North American region is leading and driven by the rising incidence of chronic and infectious diseases, with hospitals, clinics, and ASCs emerging as the major revenue generators. The hospital end-user segment is dominating the market and accounted for a 55% market share.
The increasing patient population and hospital admissions due to the pandemic cases of COVID-19 is increasing the demand for needles and syringes during the forecast period.
Becton, Dickinson and Company, B Braun Melsungen, Nipro Corporation, Terumo, and Teleflex are the key players.
The market is majorly driven by the rising incidence of trauma cases (accidents and burn cases), the growing prevalence of chronic diseases, and the increasing incidence of hospital-acquired infections.
Read More

Select a license type that suits your business needs

Single User Licence
$3500.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5 User Licence
$4000.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Corporate Licence
$5000.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Datasheet Licence
$1500.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Select a license type that suits your business needs

Best Value Tag
Coming Soon
  • Stay tuned with us.

YOU CAN GET A FREE SAMPLE OF THIS REPORT!

Fill out your details & get your free sample

Our Clients

Licence Types What are these?

Our Clients Speak

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date